Publicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (204)

2023

  1. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  4. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

  5. Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

    Antioxidants, Vol. 12, Núm. 2

  6. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  7. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis

    Frontiers in Physiology

  8. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 43, pp. 1-36

  9. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

  10. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

    Nutrients, Vol. 15, Núm. 6

  11. Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO2 study

    Frontiers in Cardiovascular Medicine, Vol. 10

  12. Targeting inflammation to treat diabetic kidney disease: the road to 2030

    Kidney International, Vol. 103, Núm. 2, pp. 282-296

  13. The Value of Klotho in Kidney Transplantation

    Transplantation, Vol. 107, Núm. 3, pp. 616-627